Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
KUNLUN ENERGY
00135
HK Stock MarketDetailed Quotes
CR MEDICAL (01515)
- 2.520
- -0.040-1.56%
Market Closed May 22 16:07 CST
3.27BMarket Cap5.96P/E (TTM)
2.590High2.480Low6.82MVolume2.570Open2.560Prev Close17.19MTurnover0.53%Turnover Ratio5.96P/E (Static)1.30BShares4.64552wk High0.45P/B3.27BFloat Cap2.48052wk Low0.14Dividend TTM1.30BShs Float16.127Historical High0.144Dividend LFY4.30%Range %2.440Historical Low2.520Avg Price500Lot Size5.71%Div Yield TTM5.71%Div Yield LFY
CR MEDICAL (01515) Cash Flow
All
YOY
| (FY)Dec 31, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | -10.85%747.67M | ---- | 70.14%838.67M | ---- | 16.55%492.92M | ---- | 56.37%422.94M | ---- | -35.32%270.48M | ---- |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | 23.63%-811K | ---- | 98.76%-1.06M | ---- | 8.59%-85.33M | ---- | -20.54%-93.35M | ---- | 3.11%-77.45M | ---- |
| Dividend (income)- adjustment | 19.75%-2.88M | ---- | 7.28%-3.59M | ---- | -19.14%-3.87M | ---- | -16.24%-3.25M | ---- | -6.76%-2.8M | ---- |
| Attributable subsidiary (profit) loss | 20.55%-78.34M | ---- | -8.62%-98.6M | ---- | -3.08%-90.78M | ---- | -5.40%-88.07M | ---- | -138.94%-83.55M | ---- |
| Impairment and provisions: | -44.84%22.37M | ---- | -91.58%40.56M | ---- | 252.24%481.37M | ---- | -61.54%136.66M | ---- | 1,410.26%355.29M | ---- |
| -Impairment of property, plant and equipment (reversal) | -99.91%30K | ---- | -84.75%32.15M | ---- | 41,231.18%210.79M | ---- | --510K | ---- | ---- | ---- |
| -Impairmen of inventory (reversal) | -88.57%55K | ---- | 122.69%481K | ---- | 1,036.84%216K | ---- | --19K | ---- | ---- | ---- |
| -Impairment of goodwill | ---- | ---- | ---- | ---- | 30.18%141.02M | ---- | --108.32M | ---- | ---- | ---- |
| -Other impairments and provisions | 181.33%22.28M | ---- | -93.88%7.92M | ---- | 365.18%129.35M | ---- | -92.17%27.81M | ---- | 1,410.26%355.29M | ---- |
| Revaluation surplus: | -128.93%-4.12M | ---- | -13.87%14.23M | ---- | 393.48%16.52M | ---- | -120.53%-5.63M | ---- | 9.06%27.42M | ---- |
| -Other fair value changes | -128.93%-4.12M | ---- | -13.87%14.23M | ---- | 393.48%16.52M | ---- | -120.53%-5.63M | ---- | 9.06%27.42M | ---- |
| Asset sale loss (gain): | -118.44%-2.06M | ---- | 369.06%11.19M | ---- | 144.43%2.39M | ---- | ---5.37M | ---- | ---- | ---- |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---- | ---5.68M | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | -113.45%-1.51M | ---- | 369.06%11.19M | ---- | 671.84%2.39M | ---- | --309K | ---- | ---- | ---- |
| -Loss (gain) from selling other assets | ---558K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization: | -5.49%584.93M | ---- | 1.32%618.9M | ---- | 25.59%610.86M | ---- | 165.97%486.41M | ---- | 61.29%182.88M | ---- |
| -Amortization of intangible assets | -60.83%1.3M | ---- | -49.22%3.31M | ---- | -2.60%6.52M | ---- | 0.01%6.69M | ---- | -15.25%6.69M | ---- |
| Financial expense | -34.16%49.56M | ---- | -42.90%75.28M | ---- | 85.30%131.84M | ---- | 298.95%71.15M | ---- | 2.55%17.83M | ---- |
| Exchange Loss (gain) | -131.90%-378K | ---- | -98.47%1.19M | ---- | -51.10%77.69M | ---- | 692.87%158.88M | ---- | 39.53%-26.8M | ---- |
| Special items | ---- | ---- | ---- | ---- | ---- | ---- | -81.02%1.92M | ---- | 454.24%10.11M | ---- |
| Operating profit before the change of operating capital | -12.51%1.3B | ---- | -8.28%1.48B | ---- | 52.85%1.62B | ---- | 57.22%1.06B | ---- | 55.54%673.41M | ---- |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | 59,026.87%39.48M | ---- | -100.10%-67K | ---- | 476.00%65.18M | ---- | -8,316.11%-17.34M | ---- | 100.91%211K | ---- |
| Accounts receivable (increase)decrease | 32.37%140.98M | ---- | 188.54%106.5M | ---- | -226.34%-120.28M | ---- | -30.77%95.2M | ---- | 48.30%137.52M | ---- |
| Accounts payable increase (decrease) | -41.22%-46.31M | ---- | 85.33%-32.79M | ---- | 18.41%-223.47M | ---- | -153.48%-273.91M | ---- | -144.84%-108.06M | ---- |
| prepayments (increase)decrease | 274.45%71.47M | ---- | -1,075.89%-40.97M | ---- | -95.82%4.2M | ---- | -24.10%100.45M | ---- | 17,023.27%132.34M | ---- |
| Special items for working capital changes | -22.75%-13.57M | ---- | 71.60%-11.06M | ---- | -599.06%-38.94M | ---- | 160.75%7.8M | ---- | -25.69%-12.84M | ---- |
| Cash from business operations | -1.01%1.49B | ---- | 15.40%1.51B | ---- | 34.40%1.31B | ---- | 18.04%970.97M | ---- | 12.32%822.58M | ---- |
| Other taxs | 43.93%-132.16M | ---- | -44.24%-235.69M | ---- | -13.60%-163.4M | ---- | -5.77%-143.84M | ---- | -38.38%-135.99M | ---- |
| Interest received - operating | ---- | ---- | ---- | ---- | 46.78%53.51M | ---- | 52.90%36.46M | ---- | 148.04%23.84M | ---- |
| Special items of business | ---- | 16.97%593.94M | ---- | -6.05%507.76M | ---- | 459.47%540.44M | ---- | -24.18%96.6M | ---- | -43.40%127.41M |
| Net cash from operations | 6.95%1.36B | 16.97%593.94M | 6.29%1.27B | -6.05%507.76M | 38.39%1.2B | 459.47%540.44M | 21.56%863.59M | -24.18%96.6M | 10.37%710.43M | -43.40%127.41M |
| Cash flow from investment activities | ||||||||||
| Dividend received - investment | 4,771.72%174.85M | -19.75%2.88M | -96.13%3.59M | -7.28%3.59M | 1,990.00%92.75M | 19.14%3.87M | 58.78%4.44M | 16.24%3.25M | 6.76%2.8M | 6.76%2.8M |
| Loan receivable (increase) decrease | -86.20%5.45M | 14.63%4M | 434.33%39.48M | 45.94%3.49M | -40.84%7.39M | -35.23%2.39M | 11.63%12.49M | 54.46%3.69M | -41.87%11.19M | -47.57%2.39M |
| Decrease in deposits (increase) | 54.78%-14.55M | 113.90%1.32M | -26.62%-32.17M | -386.13%-9.49M | -838.55%-25.41M | 369.59%3.32M | -73.25%3.44M | -107.06%-1.23M | 173.85%12.86M | --17.42M |
| Sale of fixed assets | 20,324.72%18.18M | -49.73%2.63M | -99.84%89K | -33.99%5.23M | 797.10%54.98M | 104.70%7.93M | 192.41%6.13M | 86.60%3.87M | -71.67%2.1M | 177.78%2.08M |
| Purchase of fixed assets | 8.79%-514.13M | 12.61%-217.07M | -15.82%-563.69M | -28.24%-248.39M | -4.38%-486.68M | -78.22%-193.69M | -134.98%-466.28M | -46.22%-108.68M | 5.30%-198.43M | -328.43%-74.33M |
| Purchase of intangible assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -260.30%-28.82M | ---- |
| Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | --5K | --50K | ---- | ---- |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---- | -2,266.56%-3.77B | ---- | 126.70%173.92M | 120.25%173.92M | -656.53%-651.28M | -832.63%-858.76M |
| Recovery of cash from investments | 94.81%300M | -9.09%50M | -95.67%154M | -97.92%55M | -25.35%3.56B | 28.47%2.64B | 12.02%4.76B | 34.03%2.06B | -38.09%4.25B | -59.95%1.53B |
| Cash on investment | -94.81%-300M | -81.82%-100M | 94.26%-154M | 97.82%-55M | 38.76%-2.68B | -18.19%-2.53B | 18.35%-4.38B | 25.15%-2.14B | 20.78%-5.37B | 40.30%-2.86B |
| Other items in the investment business | -49.79%4.01M | 101.51%238K | -98.74%7.98M | -103.43%-15.71M | 203.48%630.72M | 3,626.31%457.93M | -2,258.13%-609.5M | 8.00%12.29M | -49.34%28.24M | 9.20%11.38M |
| Net cash from investment operations | 40.12%-326.2M | 2.02%-256.01M | 79.23%-544.73M | -165.53%-261.29M | -430.77%-2.62B | 5,417.64%398.71M | 74.48%-494.02M | 100.33%7.23M | -3,307.23%-1.94B | -166.31%-2.22B |
| Net cash before financing | 42.29%1.03B | 37.10%337.93M | 150.84%725.54M | -73.75%246.48M | -486.12%-1.43B | 804.55%939.14M | 130.15%369.57M | 104.97%103.82M | -274.08%-1.23B | -244.03%-2.09B |
| Cash flow from financing activities | ||||||||||
| New borrowing | 18.89%2.05B | 56.14%1.78B | -68.95%1.72B | -41.22%1.14B | -35.52%5.55B | -55.85%1.94B | 41.85%8.61B | 47.96%4.39B | 1,233.95%6.07B | 2,139.09%2.97B |
| Refund | -15.17%-2.83B | -44.44%-1.85B | 57.51%-2.45B | 32.41%-1.28B | 33.03%-5.77B | 56.98%-1.9B | -69.39%-8.62B | -122.59%-4.41B | -1,513.32%-5.09B | ---1.98B |
| Interest paid - financing | 39.31%-38.66M | 36.17%-19.71M | 45.21%-63.7M | 43.32%-30.88M | -106.16%-116.27M | -302.93%-54.49M | -185.20%-56.4M | -65.06%-13.52M | -39.06%-19.77M | 11.78%-8.19M |
| Dividends paid - financing | -16.05%-179.02M | ---- | -177.78%-154.27M | ---- | 57.33%-55.53M | -2,085.82%-11.87M | -30.20%-130.14M | 99.40%-543K | 20.49%-99.96M | 21.34%-91.08M |
| Absorb investment income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -65.46%544K | ---- |
| Other items of the financing business | ---- | ---- | ---- | ---- | ---- | ---- | ---474K | ---- | ---- | -345.42%-724K |
| Net cash from financing operations | -8.67%-1.07B | 37.45%-120.26M | -125.31%-984.8M | -426.70%-192.27M | -95.40%-437.08M | 17.57%-36.5M | -126.44%-223.69M | -105.03%-44.29M | 11,559.71%845.96M | 11,387.69%879.84M |
| Effect of rate | -83.87%80K | -289.62%-347K | 251.77%496K | -73.78%183K | -94.84%141K | -60.00%698K | 16.84%2.73M | 139.91%1.75M | 253.85%2.34M | -461.02%-4.37M |
| Net Cash | 85.42%-37.79M | 301.50%217.66M | 86.09%-259.26M | -93.99%54.21M | -1,377.84%-1.86B | 1,416.10%902.64M | 138.42%145.88M | 104.92%59.54M | -154.50%-379.66M | -101.74%-1.21B |
| Begining period cash | -20.93%977.33M | -20.93%977.33M | -60.13%1.24B | -60.13%1.24B | 5.04%3.1B | 5.04%3.1B | 9.26%2.95B | 9.26%2.95B | 34.65%2.7B | 34.65%2.7B |
| Cash at the end | -3.86%939.62M | -7.43%1.19B | -20.93%977.33M | -67.76%1.29B | -60.13%1.24B | 32.88%4B | 33.39%3.1B | 102.61%3.01B | -13.97%2.32B | 5.63%1.49B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | KPMG | -- | KPMG | -- | KPMG | -- | Ernst & Young | -- | Ernst & Young | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome
牛牛課堂
Oct 13, 2025 18:05
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
Food流油
Apr 14, 2025 15:43
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"